CompletedNCT04167306
Varenicline and Bupropion for Alcohol Use
About this title
Varenicline and Bupropion for Alcohol Use Disorder
Read the official source — NCT04167306Medication studyAges 25–70SwedenAddiction
Understand this study
Who was this study for?
Listed age limits: 25 years to 70 years.
- Listed locations
- Malmö and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: March 4, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 388
- Sponsor
- Vastra Gotaland Region
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Sweden
- Age range
- From 25 Years to 70 Years
- Official registry ID
- NCT04167306
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled Multicenter Trial on the Efficacy of Varenicline and Bupropion in Combination and Alone, for Treatment of Alcohol Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Malmö · Linköping · Stockholm
1 more locations
- Gothenburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Vastra Gotaland Region.
Did this study involve medication?
Yes. The study involved medication, including Varenicline Tartrate 1 mg b.i.d and Bupropion Hydrochloride 150 mg b.i.d.
Who was this study for?
Listed age limits: 25 years to 70 years.
